Introduction
CA125 antigen is a human cancer antigen identified through binding by OC125, which is a monoclonal IgG1 antibody produced by somatic hybridization of spleen cells from BALB/c mice immunized with the OVCA 433 epithelial ovarian cancer cell line established from a patient with serous papillary cystadenocarcinoma (Bast et al., 1981) . Since this initial finding in 1981 indicating a specific association of CA125 to ovarian neoplasms, a wealth of literature on its clinical application for screening, detection, and management of gynecologic malignancies has accumulated (Montz, 1992 , Bergan et al., 2007 . Currently, it is recognized as a serum tumor marker for routine monitoring of patients with ovarian cancer (Duffy et al., 2005) .
Quantification of CA125 antigen in circulation is actually related to measuring the concentration of a proteolytically released extracellular portion of mucin 16 (MUC16). Thus, investigations of its basic molecular nature, i.e. the high molecular mass glycoprotein complex where it resides, and partial cloning of the muc16 gene led to its definition as a repeating peptide epitope on MUC16 (Yin et al., 2001) . The epitope map of CA125 is, however, very complex and varies among mucin molecules expressed under different pathophysiological conditions and from different sources. This results in typical/unique patterns sharing some commonality .
Structural data obtained on CA125/MUC16 indicated extreme heterogeneity, probably due to the existence of molecular species differing in mass and glycosylation. CA125-immunoreactivity was associated with high molecular mass macromolecular moieties of 3-5 MDa mucin and 400 kDa-200 kDa precursors, but also with low molecular mass species at 55 and 40, down to 10-15 kDa (Hanisch et al., 1985; Nustad et al., 1998; Yin et al., 2001) . As for glycosylation, the total glycan content varied from moderate, as in glycoproteins, to extremely high (more than 28%), as in mucins (Kui Wong et al., 2003) . Relatively high abundance of N-glycans, not typical for other mucins and diverse O-glycan associated epitopes such as CA19-9 and sTn, have been reported (Davis et al., 1986; Kui Wong et al., 2003; Akita et al., 2012) .
The available data on CA125 in human seminal plasma (hSP), where its concentration is relatively low, are very scarce (Halila, 1985; Matorras et al., 1994; Meisser et al., 1996) . The results of proteomic analyses differ, since one study reported CA125/MUC16 as a constituent of hSP, whereas another failed to detect this antigen (Russo et al., 2006; Milardi et al., 2012) . In general, conflicting data on the presence of other types of mucins were also observed when hSP was analyzed. This may be partially related to known interindividual sample variations due to the predominance of content of extracellular origin (Russo et al., 2006; Yamakawa et al., 2007) .
Characterization of CA125 antigen from hSP fits within the concept of protein speciation aiming at the description and characterization of all molecular species of a single protein/molecule in a specified subproteome and time. Thus, the CA125 antigen reaches hSP after undergoing four main processes involved in protein speciation: synthesis, posttranslational modification, compartmentalization (membrane or secreted form), and auto/proteolytic degradation during liquefaction (Jungblut et al., 2008; Schluter et al., 2009) . Taking this into account, we hypothesize that CA125 in human seminal plasma exists as a heterogeneous molecular species.
The present study represents an initial contribution to defining the glyco-immunoreactive profile of CA125 in hSP as a source of antigen expressed under normal physiological conditions. In these terms, we add new value relevant for general basic knowledge on this still-elusive biomarker mucin molecule. Previous investigations of cancer-and noncancer-derived CA125 antigen from other sources revealed distinct properties that influence its potential as a biomarker and modify its ligand capacity and subsequent biological activity (Jankovic et al., 2008; Mitic et al., 2012) , involving the glycan part of the molecule. These data were acquired using plant lectins: proteins that bind to specific configurations of oligosaccharide molecules, based on their composition, linkage, and type. They are also used here as a tool for analysis of seminal plasma CA125-associated glycans.
As a specific and unexplored source, hSP may be of interest in the context of MUC16/CA125 speciation, since signatures of its molecular species, in terms of molecular mass epitope distribution and glycosylation, may reflect different physiological processes in the male reproductive tract. The silver stain kit and SDS-PAGE molecular mass standards (broad range) were from Bio-Rad (Hercules, CA, USA). Pierce ECL Western Blotting Substrate was purchased from Thermo Scientific (Rockford, IL, USA). Sepharose 4B was from Pharmacia AB (Uppsala, Sweden). CA125 concentration was quantitated using the commercially available ELSA CA125 II immunoradiometric assay (Cisbio Bioassays, Codolet, France), according to the manufacturer's instructions.
Materials and methods
All other reagents were p.a.
Human semen samples
Leftover specimens of human semen from anonymized subjects taken for routine analysis of fertility were obtained according to guidelines of 'The rules of procedures of Ethics committee of INEP' (No. 02-832/1). Sperm parameters were assessed according to the recommended criteria of the World Health Organization (1999) in terms of numbers, morphology and motility. Samples with over 20 × 10 6 spermatozoa/mL, with >70% presenting normal morphology and >50% motility, were deemed normospermic and used for further analysis. Sperm cells and other debris were removed from the ejaculate by centrifugation at 800 × g for 20 min. Seminal plasma was stored at -20 °C until required.
Isolation of acid-soluble mucin-enriched fraction by perchloric acid (PCA) precipitation
An acid-soluble mucin-enriched fraction was isolated from pooled individual hSP samples (n = 15) by PCA precipitation as previously described with slight modifications (Baeckström et al., 1991) . The supernatant, containing proteins soluble in 0.1 M PCA, was separated by centrifugation at 7000 × g for 30 min, additionally filtered and then neutralized by the addition of 1M TRIS, pH 8.0. It was dialyzed against 0.05 M phosphate buffered saline (PBS), pH 7.2, for 18 h at 4 °C and stored at -20 °C until further use. Concentration of CA125 antigen in seminal plasma samples was determined using ELSA CA125 II immunoradiometric assay, and samples with detectable levels of CA125 antigen (15-325 IU/mL) were used for further analysis.
Iodination
Anti-CA125 antibody (clone X306) was labeled with radioiodine ( 125 I) using the chloramine T method as described by Greenwood et al. (1963) . The labeled antibody was separated from free iodine on a Sephadex G-75 column (10 mL bed volume) and equilibrated with 0.05 M PBS, pH 7.2, containing 0.05% bovine serum albumin.
Gel filtration
The sample (1 mL of total hSP or acid-soluble hSP preparation) was loaded on a Sepharose 4B column (bed volume 35 mL, 1.2 × 31.3 cm), equilibrated, and eluted with 0.05 M PBS, pH 7.2, at 60 mL/h. The elution was monitored by measuring absorbance at 280 nm in each fraction (1 mL). The peak fractions starting to elute at void volume (fractions 17-21) were pooled for further analysis. Alternatively, the gel filtration pull-down assay was performed as follows: the acid-soluble hSP preparation was incubated with an I 125 -anti-CA125 antibody overnight at room temperature (RT) and subjected to gel filtration. Elution was monitored by measuring radioactivity (cpm) in each fraction on a Wallac Wizard 1470 Gamma Counter (Perkin Elmer, Monza, Italy).
SDS-PAGE and Western and dot blot
Samples were subjected to electrophoresis under reducing (in a sample buffer containing 5% β-mercaptoethanol) or nonreducing conditions (in a sample buffer without 5% β-mercaptoethanol) on 6%/10% separating gels and 4% stacking gel, according to Laemmli (1970) . The gel was calibrated with SDS-PAGE molecular weight standards (broad range) (Bio-Rad) and stained using silver nitrate.
Alternatively, proteins were transferred onto Immobilon P PVDF membrane (Merck KgaA) by semidry blotting using a Trans-blot SD (Bio-Rad). The conditions were as follows: transfer buffer and 25 mM TRIS containing 192 mM glycine and 20% methanol, pH 8.3, under a constant current of 1.2 mA/cm 2 for 1 h. The membrane was blocked with 3% BSA in 0.05 M PBS, pH 7.2, for 2 h at RT, and then subjected to immuno-or lectin blot analysis.
For dot blot, the samples (3 µL droplets) were instilled on the membrane, dried, and blocked as described above.
Immunoblot
For immunoblotting, the membrane was incubated with the appropriate antibodies (anti-CA125: 2 µg/mL; anti-Le x and anti-Le y : 1:500) overnight at 4 °C. After a washing step, the appropriate biotinylated secondary antibody (1:10,000 goat antimouse IgG or 1:2000 IgM) was added and left for 1 h at RT. The membrane was then rinsed and the avidin/ biotinylated horseradish peroxidase (HRPO) mixture from the Elite Vectastain ABC kit (prepared according to the manufacturer's instructions) was added, followed by incubation for 30 min at RT. After another washing step, the blots were visualized using Pierce ECL Western blotting substrate according to the manufacturer's instructions. For determining nonspecific binding, the primary antibody was omitted from this procedure.
Lectin blot
The membrane was incubated with the chosen biotinylated plant lectin (Table) at 0.2 µg/mL in 0.05 M PBS, pH 7.2, for 1 h at RT and then washed six times in 0.05 M PBS, pH 7.2. HRPO from Vectastain Elite ABC kit was added and incubated for 30 min at RT. The membrane was then rinsed again six times in 0.05 M PBS, pH 7.2, and proteins were visualized using ECL substrate solution, according to the manufacturer's instructions.
Results

Patterns of CA125-immunoreactive species in hSP preparations as revealed by monoclonal anti-CA125 antibodies
The mucin-enriched preparation from hSP isolated on the basis of acid solubility was subjected to gel filtration on a Sepharose 4B column to separate high molecular mass from low molecular mass components. Protein peak fractions starting to elute at void volume ( Figure 1A ) exhibited CA125-immunoreactivity, as shown by dot blot ( Figure 1B ) and anti-CA125 antibody pull-down assay ( Figure 1C ).
Under denaturizing, in both reducing and nonreducing conditions the acid-soluble sample showed faint silver staining (Figures 2A and 2B ) in the stacking gel and at the border of the stacking and separating gels, characteristic of mucin appearance on SDS-PAGE. In addition, the staining revealed several bands in the range of 45-130 kDa, with characteristic enrichment of particular bands under reducing conditions (Figure 2A ). Under nonreducing conditions, CA125-immunoreactivity was seen as faint smears associated with high molecular mass glycoproteins and also as smeared bands between 116 and 200 kDa, using both X306 ( Figure 3A ) and X325 ( Figure 3B ) antibodies. However, no immunoreactive bands were detected under reducing conditions, irrespective of the antibody used ( Figures 3C  and 3D) .
To resolve the possible influence of exposure to low pH conditions during PCA precipitation, high molecular mass components separated from total hSP by gel filtration were analyzed by immunoblot using the same procedure as for the acid-soluble preparation. CA125-immunoreactivity (using the X325 antibody) was found to be preserved under reducing conditions, associating with bands between 116 and 200 kDa and an additional smeared band at 100 kDa ( Figure 3E ). Using the X306 clone gave the same pattern with very faint staining (data not shown).
Patterns of glycan-containing molecular species in hSP preparations as revealed by lectins and carbohydratebinding antibodies
To complement data on size distribution and conformation in protein-dependent CA125-immunoreactive species, the patterns of glycans across high molecular mass fractions from total hSP and corresponding acid-soluble preparations were analyzed (Figure 4) .
In total hSP, intense staining of the smear in the stacking gel was observed under reducing conditions, using WGA (specific for core 2 O-glycans containing polylactosamine chains) ( Figure 4A ) and antibodies to fucosylated Lewis glycotopes, Le x and Le y ( Figures 4B and 4C ). In addition, intense Le x -reactive bands were also detected at 100 and 130 kDa ( Figure 4B ). In contrast to this, SNA (specific for alpha 2,6Gal/GalNAc in N-glycans and sTn antigen in O-glycans) and PHA-E (specific for bisected N-glycans) stained bands faintly in the lower molecular mass region of 66-150 kDa ( Figures 4D and 4E) .
Thus, anti-Le x -stained bands (high and lower molecular masses) and partially SNA-, PHA-E-and antiLe y -stained bands (lower molecular masses) resemble/ overlap with the CA125-immunoreactive bands in total hSP ( Figure 3E ).
In the acid-soluble preparation, under reducing conditions, WGA-, Le x -, and Le y -reactive smears were also observed ( Figures 4F-4H ), but differences were found in the lower molecular mass region. Anti-Le x -and anti-Le y -staining was reduced, if present at all, and associated with lower molecular mass bands than those observed for total hSP. As for SNA-and PHA-E-reactive species, they were numerous and intense, exhibiting partially overlapping patterns of closely migrating bands ( Figures 4I and 4J ).
Discussion
Using monoclonal antibodies recognizing two previously defined main immunogenic areas of the CA125 antigen (Nustad et al., 1996) , overlapping patterns of distinct immunoreactive species were observed in normal hSP. It comprised a large, heavily glycosylated moiety, as well Figure 3 . Patterns of CA125-immunoreactive species in human seminal plasma. CA125-immunoreactive fractions from the mucinenriched acid-soluble preparation were separated via gel filtration and subjected to SDS-PAGE electrophoresis on 10% gel under denaturizing nonreducing (A, B) or reducing (C, D) conditions, followed by immunoblot analysis using anti-CA125 antibodies: clone X306 (A, C) or X325 (B, D). Immunoblot analysis of the high molecular mass fraction separated from total hSP by gel filtration using the same procedure as for the acid-soluble preparation using antibody X325 indicated preserved CA125-immunoreactivity under reducing conditions (E). The band at 45 kDa results from nonspecific binding. The numbers on the right indicate the position of molecular mass standards (kDa).
as a mixture of low glycosylated proteins ranging from 97 kDa to well over 200 kDa, all supposed to originate from monomeric MUC16, which is estimated to be the largest member of the mucin family, having an amino acid moiety of 22156 AA (O'Brien et al., 2001 Perez and Gipson, 2008) . MUC16 can be cleaved between the N-and C-terminal fragments, possibly in the SEA (sea urchin sperm protein, enterokinase, and agrin) domain, with potential influence on immunoreactivity, since both epitopes for OC125 and M11-like antibodies contain parts of two consecutive SEA domains with a linker (Maeda et al., 2004; Blalock et al., 2008) . So far, proteomic profiling identified a 2351.2 kDa protein/spot as high molecular mass MUC16/CA125 (Milardi et al., 2012) , but a CA125-immunoreactive band at 130 kDa was also observed in another immunoblot study (Halila, 1985) . Although the occurrence of several low molecular mass CA125-immunoreactive species was reported for different sources, their origin is still not elucidated, in contrast to the high molecular mass species. They are supposed to result from auto/proteolytic activity and muc16 gene polymorphism, but there is also a suggestion that some of them are actually cross-reactive molecules (Weiland et al., 2012; McLemore et al., 2016) .
The results obtained in this study indicate common patterns of immunoreactive species as revealed by both the X306 and the X325 antibody. The latter antibody has the strongest similarity to antibody M11, which is generally reactive with all the repeats and more represented, whereas X306 is an OC125-like antibody reported to have a restricted epitope distribution that nonetheless exhibits some level of cross-reactivity (Weiland et al., 2012) . Thus, in the context of origin and specificity/identity of the lower molecular mass components, the patterns obtained might be related to distinct (auto) proteolytically released glycospecies containing CA125 epitope(s) recognized by these two antibodies from different antibody groups.
The CA125 epitope(s) is defined as a conformational epitope, although there is no consensus about its structure. This epitope is reported to be localized in the 21 amino acid loop of the tandem repeat region and includes disulfide bonding of cysteine between positions 59 and 79 (O'Brien et al., 2001 , Maeda et al., 2004 . On the other hand, there are data indicating that it is not a continuous epitope, but is dependent on the secondary structure of MUC16 tandem repeats (Bressan et al., 2013) . In relation to all this, recognition of CA125 is supposed to be dependent on the conditions used for immunodetection as well as on the molecular forms/species present in the sample evaluated. Data obtained using various anti-CA125 antibodies indicated immunoreactive bands in samples of different origin under both reducing and nonreducing conditions. This may be due to the renaturated conformation of the SEA domain upon Western blot (Bressan et al., 2013) , but it was also suggested that epitope conformation on shorter moieties may be lost, leading to a lack of immunoreactive bands of lower molecular mass.
In this study, the detection of CA125-immunoreactive bands was found to be dependent on the antigen source, i.e. whether examining total unfractionated hSP or corresponding acid-soluble hSP preparations. Thus, under reducing conditions, CA125 immunoreactivity was preserved in total hSP, but lost in acid-soluble hSP preparations, which may suggest sensitivity of the epitopes to low pH. A mucin preparation obtained at a low pH would probably be prone to partial (hydrophobic) aggregation (Hong et al., 2005) but it has been reported that similar conditions could promote protease activity or lead to autoproteolytic cleavage in the sample (Lidell et al., 2003) . A possible explanation is that low pH induces proteolytic cleavage, resulting in nicked mucin molecules held together under nonreducing conditions, but destroyed under reducing conditions, as seen for MUC5AC and MUC5B in cystic fibrosis (Thornton et al., 1991; Davies et al., 2007; Henderson et al., 2014) . This influence on conformation and presentation of the CA125 epitope may lead to the observed changes in the patterns of immunoreactive bands under nonreducing versus reducing conditions. Moreover, proteolytic cleavage of any component in the sample can result in the release of additional low molecular mass fragments migrating to the same position as immunoreactive bands, impairing their accessibility to antibody binding.
It was shown that neither N-or O-glycosylation substantially influence the binding of OC125-and M11-antibodies (Marcos-Silva et al., 2014) but this should not be neglected, since mucins are highly glycosylated molecules. In general, mucins, including MUC16, are characteristic for so-called protease-sensitive naked region(s) containing no or little carbohydrates and highly O-glycosylated region(s) rich in Ser, Thr, and Pro that are resistant to proteolysis (Roberton et al., 1989; Thornton et al., 1990) . Having in mind all the limitations of indirectly approaching glycosylation of CA125-immunoreactive species, we compared the combined glyco/antigenic/molecular mass profiles of total hSP with the corresponding acid-soluble preparations under reducing conditions. As it is more specific and demanding, carbohydrate binding was used to obtain a comprehensive profile of lower molecular mass protein species. Taken together, lectin-/anti-Lewis antigen-binding patterns indicated that the Le x glycotope overlapped with CA125-immunoreactive bands across the entire range of observed molecular masses. Loss of immunoreactivity in the acidsoluble preparation under reducing conditions may be related to the presumed proteolytic degradation, since less intense staining of smears and a shift to lower molecular mass bands was observed in the Le x -pattern. In accordance with this, patterns of lower molecular mass SNA-and PHA-E-reactive bands indicated greater abundance over a broader mass range in acid-soluble preparations. These lectin-binding patterns suggest that, under reducing conditions, other glycosylated proteins with molecular mass corresponding to low abundant SNA/PHA-Ereactive CA125-derived species may be released and may obscure them from view. To illustrate this, the observed 130 kDa band, enriched under reducing conditions, does not contribute to CA125-immunoreactivity associated with the band having the same electrophoretic mobility.
This band was previously suggested to be associated with MUC5B as the main hSP mucin (Roberton et al., 1989; Nordman et al., 2002) .
Extremely complex mucin structures influence accessibility and proper exposure of particular epitopes (Bjerner et al., 2002) . This is especially apparent when using antibodies specific for the protein core, i.e. a distinct amino acid sequence in particular tandem repeat(s). Thus, an immunometric test usually measures only one fraction of a heterogeneous analyte in the examined sample (Bjerner et al., 2002; Nustad et al., 2002) , as many epitopes residing on different molecular mass forms are inaccessible or the antibodies used have low affinity for them . The same might hold true for immunoblot analysis, which is additionally influenced by the mode of sample preparation and binding reactions to the immobilized mucin molecule.
Within the bulk of abundant hSP mucins, immunoblot analysis indicated recurrent CA125-immunoreactive bands of lower molecular mass in the region present in most hSP preparations as referent and discriminative. However, caution must be applied, since they seem to be proteolysis-derived and sensitive to the redox environment. Both conditions are known to influence the nature/composition of hSP significantly (LaFlame et al., 2013; Sharma et al., 2013) and could independently affect speciation of particular molecules under both normal and pathophysiological conditions. As the pattern of CA125 molecular species may change in different pathophysiological conditions, it could be potentially utilized as a diagnostic target where alterations in glycosylation denote an ongoing pathological change. Thus, these alterations in mucin(s) glycosylation coupled with activity of hSP proteolytic enzymes and varying pH conditions in the female reproductive tract (Suarez and Pacey, 2006) could make it more sensitive or resistant to environmental conditions and consequently affect its biological functions.
In general, there are conflicting views about the structure of CA125 molecules from different sources. These may be due to both specificities of the structure and limitations of available experimental techniques (Bouanane and Miled, 2010) . Together with earlier findings, the results obtained here suggest that a combination of different affinity-and immunoreactivity-based approaches, including special care regarding sample collection and preparation, is necessary for CA125/MUC16 to be used as a reliable biomarker in the hSP proteome.
